Cargando…
The Benefits and Hazards of Intravitreal Mesenchymal Stem Cell (MSC) Based-Therapies in the Experimental Ischemic Optic Neuropathy
Mesenchymal stem cell (MSC) therapy has been investigated intensively for many years. However, there is a potential risk related to MSC applications in various cell niches. Methods: The safety of intravitreal MSC application and the efficacy of MSC-derived conditioned medium (MDCM) were evaluated in...
Autores principales: | Wen, Yao-Tseng, Ho, Yu-Chieh, Lee, Yueh-Chang, Ding, Dah-Ching, Liu, Pei-Kang, Tsai, Rong-Kung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924624/ https://www.ncbi.nlm.nih.gov/pubmed/33672743 http://dx.doi.org/10.3390/ijms22042117 |
Ejemplares similares
-
Neuroprotective effects of low-dose G-CSF plus meloxicam in a rat model of anterior ischemic optic neuropathy
por: Liu, Pei-Kang, et al.
Publicado: (2020) -
Use of Intravitreal Dexamethasone in a Case of Anterior Ischemic Optic Neuropathy
por: Nuzzi, Raffaele, et al.
Publicado: (2017) -
Author Correction: Neuroprotective effects of low-dose G-CSF plus meloxicam in a rat model of anterior ischemic optic neuropathy
por: Liu, Pei-Kang, et al.
Publicado: (2021) -
Intravitreal Injection of Long-Acting Pegylated Granulocyte Colony-Stimulating Factor Provides Neuroprotective Effects via Antioxidant Response in a Rat Model of Traumatic Optic Neuropathy
por: Huang, Chin-Te, et al.
Publicado: (2021) -
Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: Is there an association?
por: Bodla, Ali A, et al.
Publicado: (2010)